Balaxi Pharmaceuticals (NSE:BALAXI) Total Assets : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Balaxi Pharmaceuticals Total Assets?

Balaxi Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2024 was ₹0 Mil.

Warning Sign:

If a company builds assets at 96.7% a year, faster than its revenue growth rate of 47.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Balaxi Pharmaceuticals's average Total Assets Growth Rate was 21.90% per year. During the past 3 years, the average Total Assets Growth Rate was 26.00% per year. During the past 5 years, the average Total Assets Growth Rate was 96.70% per year.

During the past 10 years, Balaxi Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 1240.40%. The lowest was 3.60%. And the median was 204.90%.

Total Assets is connected with ROA %. Balaxi Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2024 was 7.45%. Total Assets is also linked to Revenue through Asset Turnover. Balaxi Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2024 was 0.25.

Balaxi Pharmaceuticals Total Assets Historical Data

The historical data trend for Balaxi Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balaxi Pharmaceuticals Total Assets Chart

Balaxi Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Assets

Get a 7-Day Free Trial

359.71

996.80

1,764.71

2,396.69

2,583.43

Balaxi Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															-	2,583.43	-	2,879.65	-

Balaxi Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Balaxi Pharmaceuticals's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (A: Mar. 2024 )	+	Total Liabilities (A: Mar. 2024 )
	=	2013.639	+	569.793
	=	2,583

Balaxi Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	N/A	+	N/A
	=	N/A

Balaxi Pharmaceuticals (NSE:BALAXI) Total Assets Explanation

Total Assets is connected with ROA %.

Balaxi Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	214.512	/	( (2879.653	+	0)	/ 1 )
	=	214.512	/	2879.653
	=	7.45 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Balaxi Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	732.913	/	( (2879.653	+	0)	/ 1 )
=	732.913	/	2879.653
=	0.25

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Balaxi Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Balaxi Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Balaxi Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Balaxi Pharmaceuticals Ltd (NSE:BALAXI) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

Phase-III, Road No: 81, Jubilee Hills, Plot No.409, H,No: 8-2-293, MAPS Towers, 3rd Floor, Hyderabad, TG, IND, 500 096

Website

https://www.balaxipharma.in

Balaxi Pharmaceuticals Ltd is an Indian branded IPR-based pharmaceutical company focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs, across multiple therapeutic segments. Geographically it earns key revenue from Guatemala.

Balaxi Pharmaceuticals Headlines

No Headlines